ClinicalTrials.govpublic full text
A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines
covid-19, sars-cov-2 infection, sars-cov-2, vaccine, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1007281
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.